z-logo
open-access-imgOpen Access
Systemic Heme Oxygenase-1 Transgenic Overexpression Aggravates Pressure Overload-induced Cardiac Hypertrophy in Mice
Author(s) -
Chang Chen,
Rong Huo,
Yan Tong,
Yue Sheng,
Huibin Liu,
Xu Gao,
Osamu Nakajima,
Baofeng Yang,
DeLi Dong
Publication year - 2011
Publication title -
cellular physiology and biochemistry
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000331710
Subject(s) - pressure overload , medicine , muscle hypertrophy , endocrinology , transgene , calcineurin , genetically modified mouse , heme oxygenase , fibrosis , chemistry , biology , heme , cardiac hypertrophy , transplantation , biochemistry , enzyme , gene
Heme oxygenase-1(HO-1) has been reported to protect against cardiac hypertrophy in cultured neonatal cardiomyocytes treated with HO-1 inducer, cardiac specific HO-1 transgenic mice, or animals treated with HO-1 inducer. The aim of the present study is to examine the effects of systemic HO-1 transgenic overexpression on pressure overload-induced cardiac hypertrophy in mice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom